I am a
Home I AM A Search Login

Papers of the Week

Papers: 5 Aug 2023 - 11 Aug 2023



Inflammation/Inflammatory, Psychological/Comorbidities

2023 Aug 04

Cochrane Database Syst Rev



Interventions for chronic kidney disease in people with sickle cell disease.


Roy NB, Carpenter A, Dale-Harris I, Dorée C, Estcourt LJ


Sickle cell disease (SCD), one of the commonest severe monogenic disorders, is caused by the inheritance of two abnormal haemoglobin (beta-globin) genes. SCD can cause severe pain, significant end-organ damage, pulmonary complications, and premature death. Kidney disease is a frequent and potentially severe complication in people with SCD. Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function present for more than three months. Sickle cell nephropathy refers to the spectrum of kidney complications in SCD. Glomerular damage is a cause of microalbuminuria and can develop at an early age in children with SCD, with increased prevalence in adulthood. In people with sickle cell nephropathy, outcomes are poor as a result of the progression to proteinuria and chronic kidney insufficiency. Up to 12% of people who develop sickle cell nephropathy will develop end-stage renal disease. This is an update of a review first published in 2017.